Table IV.
Treatment | n | GVT | Fused (%) | Nuclear status after in vitro maturation (%) |
n | Developmental competence after in vitro fertilization (%) |
|||
---|---|---|---|---|---|---|---|---|---|
MII or MII/fused | Normal MII spindle | Cleaved/MII | Morulae/cleaved | Blastocysts/cleaved | |||||
None | 95 | − | 78.2 ± 6.5a,c | 89.2 ± 5.8a | 91 | 77.1 ± 5.4a | 29.4 ± 3.2a | 35.3 ± 6.0a | |
92 | + | 75.0 ± 2.9a | 56.4 ± 4.9b | 82.0 ± 12.5a | 92 | 63.6 ± 8.1b | 28.6 ± 9.2a | 14.3 ± 8.3b | |
GV compaction | 91 | − | 80.4 ± 3.3c | 89.0 ± 6.3a | 90 | 73.2 ± 4.1a,b | 30.0 ± 3.9a | 36.7 ± 2.7a | |
91 | + | 69.7 ± 6.1a | 60.6 ± 6.5b | 84.2 ± 9.2a | 93 | 68.3 ± 5.5a,b | 27.8 ± 9.2a | 16.7 ± 8.3b | |
Vitrification | 95 | − | 52.7 ± 6.3b | 44.0 ± 12.0b | 89 | 31.0 ± 7.9c | 0b | 0c | |
92 | + | 73.5 ± 4.4a | 51.5 ± 8.1b | 83.3 ± 7.8a | 91 | 58.8 ± 7.5b | 10.4 ± 6.3c | 14.5 ± 9.2b | |
GV compaction + vitrification | 91 | − | 70.6 ± 5.7a | 89.1 ± 8.2a | 88 | 69.4 ± 7.6a,b | 21.0 ± 9.0a,c | 16.4 ± 10.2b | |
92 | + | 71.5 ± 8.5a | 53.1 ± 5.2b | 82.9 ± 10.8a | 95 | 64.7 ± 7.0b | 27.3 ± 5.6a | 15.1 ± 9.4b |
Within columns, values (mean ± SD; six replicates) with different superscripts are different (P< 0.05). MII, metaphase II.